Media-OutReach Newswire 2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies
Media-OutReach Newswire Li Ka Shing Foundation and Temasek Trust Jointly Commit S$12 Million to Acquire Systems and Advance Clinical Trial for Innovative Histotripsy Cancer Therapy in Singapore
Media-OutReach Newswire Beijing Tong Ren Tang Joins Hands with CMHK Education Platform - Edubile to Launch Inaugural "Hong Kong Student Ambassador Programme for Chinese Medicine and Health Care
Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist